1. Caminier GW, Smith CG (1965) Studies of the enzymatic deamination of cytosine arabinoside. Biochem Pharmacol 14: 1405
2. Capizzi RL, Powell BL (1987) Sequential high dose ara-C and asparaginase versus high dose ara-C alone in the treatment of patients with relapsed and refractory acute leukemias. Semin Oncol 14 [Suppl 1]: 40
3. Capizzi RL, Yang J-L, Cheng E, Bjornson D, Sahasrabudhe D, Tan R-S, Cheng Y-C (1983) Alteration of the pharmacokinetics of high dose ara-C by its metabolite high ara-U in patients with acute leukemia. J Clin Oncol 1: 763
4. Capizzi RL, Yang J-L, Rathmell JP, White JC, Cheng E, Cheng Y-C, Kute T (1985) Dose-related pharmacologic effects of high dose ara-C and its self-potentiation. Semin Oncol 12 [Suppl 3]: 65
5. Caradonna SJ, Cheng Y-C (1980) The role of deoxyuridine triphosphate nucleotidohydrolase, uracil-DNA glycosylase, and DNA polymerase ? in the metabolism of FUdR in human tumor cells. Mol Pharmacol 18: 513